[1]
|
Oscar, A. (2000) Carretero and Suzanne Oparil. Essential Hypertension: Part I: Definition and Etiology. Circulation, 101, 329-335.
|
[2]
|
Psaty, B.M., Lumley, T., Furberg, C.D., Schellenbaum, G., Pahor, M., Alderman, M.H. and Weiss, N.S. (2003) Health Outcomes Associated with Various Antihypertensive Therapies Used as First-Line Agents: A Network Meta-Analysis. JAMA, 289, 2534-2544. http://dx.doi.org/10.1016/s1062-1458(03)00272-1
|
[3]
|
Chobanian, A.V., Bakris, G.L., Black, H.R., Cushman, W.C., Green, L.A., Izzo, J.L., Jones, D.W., Materson, B.J., Oparil, S., Wright, J.T. and Roccella, E.J. (2003) Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. Hypertension, 42, 1206-1252. http://dx.doi.org/10.1161/01.HYP.0000107251.49515.c2
|
[4]
|
Boschin, G., et al. (2014) Optimization of the Enzymatic Hydrolysis of Lupin (Lupinus) Proteins for Producing ACE-Inhibitory Peptides. Journal of Agricultural and Food Chemistry, 62, 1846-1851. http://dx.doi.org/10.1021/jf4039056
|
[5]
|
Gavras, I. and Gavras, H. (2004) Hypertension, Vasoactive Peptides and Coagulation Factors. Journal of Hypertension, 22, 1091-1092. http://dx.doi.org/10.1097/00004872-200406000-00007
|
[6]
|
Wilhelmsen, L., Svardsudd, K., Koran-Bengtsen, K., Larsson, B., Weilin, L. and Tibblin, G. (1984) Fibrinogen as a Risk Factor for Stroke and Myocardial Infarction. New England Journal of Medicine, 311, 501-505. http://dx.doi.org/10.1056/NEJM198408233110804
|
[7]
|
Ibrahim, H.M.A. and Abdalla, M.H.A. (2014) D-Dimer Levels in Sudanese Hypertensive Patients. American Journal of Medicine and Medical Sciences, 4, 92-95.
|
[8]
|
Osman, S.S.A., Ali, A.E. and Muddathir, A.R.M. (2014) Measurements of Plasma Fibrinogen Level, Total Cholesterol and Triglyceride Levels in Hypertensive Sudanese Patients. American Journal of Medicine and Medical Sciences, 4, 161-165.
|
[9]
|
Ali, N.M.A., Gameel, F.E.M.H., Elsayid, M. and Babker, A.M.A.A.A. (2016) Alterations in D-Dimer, Prothrombin Time and Activated Partial Thromboplastin Time as Thrombogenesis Activity Markers in Patients with Acute Myocardial Infarction. Open Journal of Blood Diseases, 6, 1-5. http://dx.doi.org/10.4236/ojbd.2016.61001
|
[10]
|
Glueck, C.J., Glueck, H.I., Hamer, T., et al. (1994) Beta Blockers, Lp(a), Hypertension, and Reduced Basal Fibrinolytic Activity. The American Journal of the Medical Sciences, 307, 317-324. http://dx.doi.org/10.1097/00000441-199405000-00001
|
[11]
|
Letcher, R.L., Chien, S., Pickering, T.G., Sealey, J.E. and Laragh, J.H. (1981) Direct Relationship between Bloodpressure and Blood Viscosity in Normal and Hypertensive Subjects. Role of Fibrinogen and Concentration. American Journal of Medicine, 70, 1195-1202. http://dx.doi.org/10.1016/0002-9343(81)90827-5
|
[12]
|
Tabak, O., Gelisgen, R., Uzun, H., Kalender, B., Balci, H., Curgunlu, A., et al. (2009) Hypertension and Hemostatic/ Fibrinolytic Balance. Clinical & Investigative Medicine, 32, E285-E292.
|
[13]
|
Bennet, N.B. and Ogston, D. (1970) Inhibitions of Fibrinolytic Enzyme System in Renal Disease. Clinical Science, 549, 30-41.
|
[14]
|
Wardle, E.N., Menon, I.S. and Rastogi, S.P. (1970) Study of Proteins and Fibrinolysis in Patients with Glomerulonephritis. British Medical Journal, 2, 260-263. http://dx.doi.org/10.1136/bmj.2.5704.260
|
[15]
|
Sechi, L.A., Novello, M., Colussi, G., et al. (2008) Relationship of Plasma Renin with a Prothrombotic State in Hypertension: Relevance for Organ Damage. American Journal of Hypertension, 21, 1347-1353. http://dx.doi.org/10.1038/ajh.2008.293
|
[16]
|
Shankar, A., et al. (2006) Positive Association between Plasma Fibrinogen Level and Incident Hypertension among Men Population-Based Cohort Study. Hypertension, 48, 1043-1049. http://dx.doi.org/10.1161/01.HYP.0000245700.13817.3c
|
[17]
|
Folsom, A.R., et al. (1998) Plasma Fibrinogen and Incident Hypertension in the Atherosclerosis Risk in Communities (ARIC) Study. Journal of Hypertension, 16, 1579-1583. http://dx.doi.org/10.1097/00004872-199816110-00003
|